INmune Bio, Inc. (INMB) Tops Q1 EPS by 7c

INmune Bio, Inc. (NASDAQ: INMB) reported Q1 EPS of ($0.20), $0.07 better than the analyst estimate of ($0.27).

For earnings history and earnings-related data on INmune Bio, Inc. (INMB) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Tops Q2 EPS by 24c
• Deutsche Bank Upgrades Huizhou Desay Sv Automotive Co (002920:CH) to Hold